Finnish man­u­fac­tur­er to in­vest $55M+ in new fa­cil­i­ty for AAV ther­a­pies

Finnish bio­phar­ma­ceu­ti­cal con­tract man­u­fac­tur­er Biov­ian Oy is in­vest­ing €50 mil­lion ($55.3 mil­lion) to ex­pand its man­u­fac­tur­ing pres­ence in Fin­land and take on large-scale vi­ral vec­tor …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER